Clinical Trials Browser

Phase 2/3 × 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid × Clear all

NCT07084909 2025-12-10

HARRIER

Phase 2/3 Withdrawn

Carcinoma, Renal Cell, Kidney Neoplasms

NCT02981368 2021-08-09

OSPREY

Phase 2/3 Completed

385 enrolled 20 charts

Disease, Prostatic Neoplasms

NCT03852654 2019-02-25

18F-DCFPyL PET-CT Scan and Prostate Cancer

Phase 2/3 Unknown

Prostatic Neoplasms